BTS
JAZZ icon

BB&T Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

BB&T Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$505K Buy
3,906
+824
+27% +$110K ﹤0.01% 1098
2019
Q2 		$439K Sell
3,082
-28
-0.9% -$3.76K ﹤0.01% 1154
2019
Q1 		$444K Buy
3,110
+315
+11% +$41.1K ﹤0.01% 1134
2018
Q4 		$346K Sell
2,795
-227
-8% -$33.7K ﹤0.01% 1128
2018
Q3 		$508K Sell
3,022
-7
-0.2% -$1.2K 0.01% 1078
2018
Q2 		$521K Buy
3,029
+1,600
+112% +$262K 0.01% 1060
2018
Q1 		$215K Sell
1,429
-489
-25% -$71.7K ﹤0.01% 1368
2017
Q4 		$258K Sell
1,918
-779
-29% -$108K ﹤0.01% 1240
2017
Q3 		$394K Sell
2,697
-157
-6% -$23.7K 0.01% 1059
2017
Q2 		$443K Buy
2,854
+925
+48% +$141K 0.01% 1013
2017
Q1 		$279K Buy
+1,929
New +$251K ﹤0.01% 1071
2016
Q3 		– Sell
-1,668
Closed -$235K – 1250
2016
Q2 		$235K Buy
+1,668
New +$246K ﹤0.01% 1087
2016
Q1 		– Sell
-3,898
Closed -$547K – 1203
2015
Q4 		$547K Sell
3,898
-51
-1% -$7.07K 0.01% 695
2015
Q3 		$524K Sell
3,949
-1,235
-24% -$213K 0.01% 687
2015
Q2 		$912K Sell
5,184
-271
-5% -$48.7K 0.02% 560
2015
Q1 		$943K Sell
5,455
-1,522
-22% -$261K 0.02% 537
2014
Q4 		$1.14M Buy
6,977
+958
+16% +$159K 0.03% 472
2014
Q3 		$966K Buy
6,019
+382
+7% +$58.7K 0.02% 481
2014
Q2 		$829K Buy
5,637
+335
+6% +$46.5K 0.02% 509
2014
Q1 		$735K Sell
5,302
-4,337
-45% -$653K 0.02% 495
2013
Q4 		$1.22M Sell
9,639
-2,486
-21% -$257K 0.03% 327
2013
Q3 		$1.12M Sell
12,125
-17,509
-59% -$1.41M 0.03% 320
2013
Q2 		$2.04M Buy
+29,634
New +$1.81M 0.07% 207

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BB&T Securities's JAZZ Position: Q3 2019 in Review

BB&T Securities increased its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q3 2019, buying an estimated $110K and bringing the position to 3,906 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

BB&T Securities first reported a position in JAZZ in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.04M in Q2 2013. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • BB&T Securities held 3,906 shares of Jazz Pharmaceuticals worth $505K as of Q3 2019.
  • BB&T Securities bought 824 Jazz Pharmaceuticals shares in Q3 2019, an estimated $110K.
  • Jazz Pharmaceuticals made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1098 holding.
  • BB&T Securities first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • BB&T Securities's Jazz Pharmaceuticals position peaked at $2.04M in Q2 2013.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.